| |
| |
|
| Insider
Information: |
Shaw Christine |
| Relationship: |
VP, Assay Development |
| City: |
Carlsbad |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
0 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Genmark Diagnostics, Inc. |
GNMK |
VP, Assay Development |
2021-04-22 |
0 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
13 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GNMK |
Genmark Diagnostics, Inc. |
VP, Assay Development |
• – – |
2021-04-22 |
4 |
D |
$24.05 |
$2,436,842 |
D/D |
(101,324) |
0 |
0 |
- |
|
| GNMK |
Genmark Diagnostics, Inc. |
VP, Assay Development |
• – – |
2021-04-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,730) |
100,466 |
0 |
- |
|
| GNMK |
Genmark Diagnostics, Inc. |
VP, Assay Development |
• – – |
2021-03-05 |
4 |
S |
$18.56 |
$5,085 |
D/D |
(274) |
102,196 |
0 |
% |
|
| GNMK |
Genmark Diagnostics, Inc. |
VP, Assay Development |
• – – |
2021-02-26 |
4 |
S |
$17.03 |
$53,662 |
D/D |
(3,151) |
102,470 |
0 |
% |
|
| GNMK |
Genmark Diagnostics, Inc. |
VP, Assay Development |
• – – |
2021-02-24 |
4 |
S |
$19.12 |
$4,952 |
D/D |
(259) |
105,621 |
0 |
% |
|
| GNMK |
Genmark Diagnostics, Inc. |
VP, Assay Development |
• – – |
2021-02-23 |
4 |
S |
$19.35 |
$3,212 |
D/D |
(166) |
105,880 |
0 |
% |
|
| GNMK |
Genmark Diagnostics, Inc. |
VP, Assay Development |
• – – |
2021-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
26,250 |
106,046 |
0 |
- |
|
| GNMK |
Genmark Diagnostics, Inc. |
VP, Assay Development |
• – – |
2021-01-27 |
4 |
S |
$14.06 |
$1,139 |
D/D |
(81) |
79,796 |
0 |
% |
|
| GNMK |
Genmark Diagnostics, Inc. |
VP, Assay Development |
• – – |
2020-12-07 |
4 |
S |
$13.97 |
$3,828 |
D/D |
(274) |
79,877 |
0 |
% |
|
| GNMK |
Genmark Diagnostics, Inc. |
VP, Assay Development |
• – – |
2020-11-24 |
4 |
S |
$13.17 |
$4,675 |
D/D |
(355) |
79,291 |
0 |
% |
|
| GNMK |
Genmark Diagnostics, Inc. |
VP, Assay Development |
• – – |
2020-10-27 |
4 |
S |
$11.34 |
$771 |
D/D |
(68) |
79,646 |
0 |
% |
|
| GNMK |
Genmark Diagnostics, Inc. |
VP, Assay Development |
• – – |
2020-09-08 |
4 |
S |
$11.02 |
$3,141 |
D/D |
(285) |
79,714 |
0 |
% |
|
| GNMK |
Genmark Diagnostics, Inc. |
VP, Assay DevelopmentOfficer |
• – – |
2020-08-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
80,378 |
|
% |
|
13 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
